Sensitivity of the SARS-CoV-2 BA.2.86 variant to prevailing neutralising antibody responses
Daniel J. Sheward, Yiqiu Yang, Michelle Westerberg, Sofia Öling, Sandra Muschiol, Kenta Sato, Thomas P. Peacock, Gunilla B. Karlsson Hedestam, Jan Albert, Ben Murrell
Topics & Concepts
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AntibodySensitivity (control systems)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakMedicineImmunologyInternal medicineOutbreakEngineeringElectronic engineeringInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies